GTx Inc. | Key People and Executives
Robert James Wills
Executive Chairman
Marc Steven Hanover
Chief Executive Officer & Director
Joseph R. Hyde
Lead Independent Director
Garry Arthur Neil
Director
Michael G. Carter
Independent Director
Kenneth S. Robinson
Independent Director
J. Kenneth Glass
Independent Director
Robert James Wills
Executive Chairman
Marc Steven Hanover
Chief Executive Officer & Director
Jason T. Shackelford
Principal Financial & Accounting Officer
Mary Ann Johnston
Vice President-Clinical Development
Diane C. Young
Chief Medical Officer & Vice President
Henry Patton Doggrell
Secretary, Chief Legal Officer & Vice President
Jeffrey G. Hesselberg
Vice President-Regulatory Affairs
Joseph R. Hyde
Lead Independent Director
Garry Arthur Neil
Independent Director
Michael G. Carter
Independent Director
Kenneth S. Robinson
Independent Director
J. Kenneth Glass
Independent Director
| Address |
175 Toyota Plaza
Memphis Tennessee 38103
United States
|
|
Employees
|
- |
| Website |
http://www.gtxinc.com |
| Updated |
09/14/2018 |
| GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. |
